ID: ALA5275790

Max Phase: Preclinical

Molecular Formula: C21H23NO2

Molecular Weight: 321.42

Associated Items:

Representations

Canonical SMILES:  Cc1cc(C(=O)/C=C/c2ccc(N3CCCCC3)cc2)ccc1O

Standard InChI:  InChI=1S/C21H23NO2/c1-16-15-18(8-12-20(16)23)21(24)11-7-17-5-9-19(10-6-17)22-13-3-2-4-14-22/h5-12,15,23H,2-4,13-14H2,1H3/b11-7+

Standard InChI Key:  OJYMFQUOVFSJRZ-YRNVUSSQSA-N

Associated Targets(non-human)

Bacillus anthracis 2936 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 321.42Molecular Weight (Monoisotopic): 321.1729AlogP: 4.59#Rotatable Bonds: 4
Polar Surface Area: 40.54Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.24CX Basic pKa: 5.28CX LogP: 5.06CX LogD: 5.00
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.66Np Likeness Score: -0.39

References

1. Dan W, Dai J..  (2020)  Recent developments of chalcones as potential antibacterial agents in medicinal chemistry.,  187  [PMID:31877539] [10.1016/j.ejmech.2019.111980]

Source